HBIO Harvard Bioscience Stock Forecast Outlook:Negative Period (n+30) 23 Feb 2021


Stock Forecast


As of Tue Feb 23 2021 00:00:02 GMT+0000 (Coordinated Universal Time) shares of HBIO Harvard Bioscience -2.17 percentage change in price since the previous day's close. Around 115837 of 38976000 changed hand on the market. The Stock opened at 4.58 with high and low of 4.5 and 4.67 respectively. The price/earnings ratio is: - and earning per share is -0.17. The stock quoted a 52 week high and low of 1.39 and 5.21 respectively.

BOSTON (AI Forecast Terminal) Tue, Feb 23, '21 AI Forecast today took the forecast actions: In the context of stock price realization of HBIO Harvard Bioscience is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+30) for HBIO Harvard Bioscience as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of HBIO Harvard Bioscience as below:

HBIO Harvard Bioscience Credit Rating Overview


We rerate HBIO Harvard Bioscience because of derivatives receivables represent more than 5% of total assets for entities reporting under IFRS (or under local GAAP similar to IFRS for the accounting of derivatives) and are domiciled in countries for which our BICRA group is '5' and above.. We use econometric methods for period (n+30) simulate with Clapp Oscillators Linear Regression. Reference code is: 3364. Beta DRL value REG 12 Rational Demand Factor LD 6070.7472. We do not assume future debt refinancing or the rolling over of CP, regardless of the company's perceived credit strength or issuer credit rating. For instance, even for investment-grade issuers, we do not assume future debt maturities are refinanced with potential uncommitted capital raises. We could, however, consider a shorter time horizon. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for HBIO Harvard Bioscience as below:
Frequently Asked QuestionsQ: What is HBIO Harvard Bioscience stock symbol?
A: HBIO Harvard Bioscience stock referred as NASDAQ:HBIO
Q: What is HBIO Harvard Bioscience stock price?
A: On share of HBIO Harvard Bioscience stock can currently be purchased for approximately 4.5
Q: Do analysts recommend investors buy shares of HBIO Harvard Bioscience ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for HBIO Harvard Bioscience at daily forecast section
Q: What is the earning per share of HBIO Harvard Bioscience ?
A: The earning per share of HBIO Harvard Bioscience is -0.17
Q: What is the market capitalization of HBIO Harvard Bioscience ?
A: The market capitalization of HBIO Harvard Bioscience is 175392000
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker, credit rating agency or route orders containing equities securities. In our Machine Learning experiment, we focus on an approach known as Decision making using game theory. We apply principles from game theory to model the relationships between rating actions, news, market signals and decision making.The rating information provided is for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. Usage as a credit rating or as a benchmark is not permitted.

301 Massachusetts Avenue Cambridge, MA 02139 667-253-1000 pr@ademcetinkaya.com